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Abstract 
Objectives: Placenta previa is a major cause of neonatal anemia. The purpose of this study 
was to elucidate the risk factors of neonatal anemia in placenta previa.  
Methods: The study was conducted on 158 placenta previa patients at 3 hospitals in affiliation 
with the Catholic Medical Center, Seoul, Korea from May 1999 through December 2009. The 
subjects were divided in to 2 groups: 47 placenta previa patients with neonatal anemia, and 
113 placenta previa patients without neonatal anemia. The subjects’ characteristics were 
compared. Logistic regression was used to control for confounding factors. 
Results: Anterior placental location (OR 2.48; 95% CI: 1.20–5.11) was an independent risk 
factor of neonatal anemia after controlling for potential confounders. 
Conclusion: To manage neonatal anemia in placenta previa patients, obstetricians should do 
their best to detect placental location. Pediatricians should consider the high possibility of 
neonatal anemia in cases involving anterior placental location. 
Key words: neonatal anemia, preterm, placenta previa 
Introduction 
The overall incidence rate of placenta previa is 
approximately 4 out of 1000 births [1]. Moreover, it is 
reported that 10% of all infants born following pla-
centa previa present with severe anemia. In addition, 
placenta previa is the most common placental anom-
aly causing neonatal anemia [2]. Together with pre-
term birth, neonatal anemia is a major factor of the 
4–8%  risk  of  perinatal  mortality  in  placenta  previa 
patients  [2].  However,  to  our  knowledge,  there  has 
been  no  study  about  the  risk  factors  for  neonatal 
anemia in placenta previa patients. In this study, we 
evaluated the risk factors of neonatal anemia in pla-
centa previa by comparing a neonatal anemia group 
with a control group.  
Patients and methods 
Subjects 
We conducted a retrospective case–control study 
on  singleton  births  after  26  gestational  weeks  com-
plicated with placenta previa in 3 hospitals affiliated 
with  the  Catholic  University  of  Korea  (Seoul:  St. 
Mary’s Hospital, St. Vincent’s Hospital, and Yeouido: 
St. Mary’s Hospital) from May 1, 1999 to December 31, 
2009. Cases were excluded if they met any of the fol-
lowing  criteria:  cases  in  which  neonates  were  not 
checked for hemoglobin levels within 24 hours after 
birth,  multiple  births,  successful  vaginal  deliveries 
among  low-lying  placentas,  and  other  placental 
anomalies such as accessory placenta and circumval-
lated placenta. Other information, including maternal 
and neonatal outcomes, was collected from medical 
records.  This  study  was  approved  by  the  Clinical 
Study Medical Ethics Committee (XC10RIMI0126V). 
Methods 
We divided subjects into 2 groups according to 
the  presence  of  neonatal  anemia:  an  anemia  group 
and a control group. The following variables of the 
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pregnancies  were  studied:  maternal  age,  previous 
cesarean sections, admission due to vaginal bleeding 
after 20 weeks of gestation, placental location by ul-
trasonography  and  operation  findings,  placenta  ac-
creta, maternal hemoglobin level prior to and 1 day 
after  surgery,  and  estimated  blood  loss  during  sur-
gery. Excessive blood loss was defined as blood loss 
>1000 mL. Cesarean sections were classified as elec-
tive or emergency. The following variables of the ne-
onates  were  studied:  gestational  age  at  birth,  birth 
weight, Apgar scores at 1 and 5 min, and  neonatal 
hemoglobin  level.  Neonatal  anemia  was  defined  as 
hemoglobin <14.5 g/dL as examined by venous sam-
pling within the first 24 hours after birth [3]. Placenta 
previa  was  classified  as  total,  partial,  marginal, 
low-lying,  or  vasa  previa  [4];  furthermore,  it  was 
classified  as  anterior  placenta  (defined  as  placenta 
located  at  the  uterine  incision  site)  or  not  [5].  The 
placenta was classified and located according to the 
results  of  the  last  transabdominal  and  transvaginal 
sonographic exams prior to delivery and confirmed at 
surgery.  
Statistical analysis 
All data were analyzed using SAS version 8 (SAS 
Institute,  Berkley,  CA,  USA).  Continuous  variables 
were  compared  using  independent  t-tests  or  the 
Mann–Whitney  U–test.  Categorical  variables  were 
compared using the χ2 or Fisher’s exact test. Multi-
variate logistic regression analysis was used to iden-
tify the independent risk factors of neonatal anemia. 
The level of statistical significance was set at p <0.05.  
Results 
The  records  from  the  11-year  study  period  re-
vealed  that  there  had  been  35,030  deliveries—560 
(1.6%) of which were complicated with placenta pre-
via. After excluding 353 cases in which neonatal he-
moglobin  levels  were  not  checked  within  24  hours 
after birth, there were 5 cases of births before 26 ges-
tational weeks, 30 vaginal births, 10 multiple births, 
and 4 births with other placental anomalies; 45 cases 
were classified into the neonatal anemia group, and 
113 cases into the control group. The maternal char-
acteristics of the anemia and control groups are listed 
in Table 1. Neonatal anemia was significantly associ-
ated with emergency cesarean section (OR 2.53; 95% 
CI: 1.08–5.97) and anterior placental location (OR 2.53; 
95% CI: 1.24–5.16). However, maternal age, previous 
cesarean  section,  admission  for  vaginal  bleeding, 
placenta accreta, and complete previa were not sig-
nificantly different between the 2 groups.  
The results of the univariate analysis regarding 
maternal and neonatal outcomes are presented in Ta-
ble 2. The gestational age of the anemia group was 
slightly lower than that of the control group (34.23 ± 
3.00 vs. 35.28 ± 2.99 weeks, respectively). In addition, 
the  incidence  of  preterm  birth  before  week  37  was 
significantly  greater  in  the  anemia  group  (OR  2.44; 
95% CI: 1.04–5.74). However, there were no significant 
differences between groups with respect to maternal 
pre-  or  post-operative  hemoglobin  levels,  neonatal 
birth weight, or Apgar score <4 at 1 or 5 min. The es-
timated blood loss during operation was significantly 
greater in the anemia group than in the control group; 
however, there was no significant difference in exces-
sive blood loss between groups.  
Table 1. Maternal characteristics of placenta previa according to the presence of neonatal anemia 
  Anemia (45)  Control (113)  OR (95% CI)  P-value 
Age (years)  32.38 (4.66)  32.82 (3.76)    0.570 
Previous C/S  0  29 (64.4%)  74 (65.5%)  1  0.411 
1  9 (20.0%)  29 (25.7%)  0.79 (0.33–1.88) 
≥2  7 (15.6%)  10 (8.8%)  1.79 (0.62–5.14) 
Admission owing to vaginal bleeding  34 (75.6%)  81 (71.7%)  1.22 (0.55–2.70)  0.621 
Placenta accreta  7 (15.6%)  15 (13.5%)  1.18 (0.45–3.12)  0.740 
Emergency C/S  37 (82.2%)  73 (64.6%)  2.53 (1.08–5.97)  0.030 
Previa  Complete  20 (44.4%)  57 (50.4%)  1  0.346 
Partial  4 (8.9%)  15 (13.3%)  0.76 (0.23–2.56) 
Marginal  4 (8.9%)  13 (11.5%)  0.88 (0.26–3.00) 
Low-lying  16 (35.6%)  28 (24.8%)  1.63 (0.73–3.62) 
Vasa previa  1 (2.2%)  0 (0%)  1.05 (0.95–1.16) 
Placenta  Anterior position  23 (51.1%)  33 (29.2%)  2.53 (1.24–5.16)  0.009 
Values are expressed as mean (SD) or number (%). 
C/S: Cesarean section. 
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Table 2. Univariate analysis of maternal and neonatal pregnancy outcomes according to the presence of neonatal anemia in 
placenta previa 
  Anemia (45)  Control (113)  OR (95% CI)  P-value 
Preop Hb (g/dL)  10.50 (1.56)  10.88 (1.48)    0.169 
POD #1 Hb (g/dL)  10.20 (1.87)  10.11 (1.58)    0.759 
Estimated blood loss (mL)  1135.56  801.77    0.029 
Excessive blood loss (mL)  14 (31.1%)  24 (21.2%)  1.68 (0.77–3.64)  0.190 
Neonatal Hb (g/dL)  12.98 (1.18)  16.39 (1.35)     <0.001 
Gestational age (weeks)  34.23 (3.00)  35.28 (2.99)    0.044 
Preterm birth  37 (82.2%)  74 (65.5%)  2.44 (1.04–5.74)  0.038 
Birth weight (kg)  2.29 (0.67)  2.49 (0.64)    0.076 
Apgar score <4 at 1 min  11 (24.4%)  14 (12.4%)  2.29 (0.95–5.52)  0.061 
Apgar score <4 at 5 min  3 (6.7%)  2 (1.8%)  3.96 (0.64–24.57)  0.113 
Values are expressed as mean (SD) or number (%).  
Preop: preoperational. 
POD #1: 1 day after operation. 
Hb: hemoglobin. 
 
 
After the multivariate logistic regression analysis 
was adjusted for estimated blood loss, preterm birth 
(≤37 weeks), emergency cesarean section, and anterior 
placental  location,  we  found  that  anterior  placental 
location (OR 2.39; 95% CI: 1.15–4.96) was more com-
mon in the anemia group, suggesting that it is an in-
dependent risk factor of neonatal anemia (Table 3). 
 
Table 3. Risk factors for developing neonatal anemia in 
placenta previa (multivariate analysis)  
  OR  95% CI  Significance 
Preterm birth*  1.56  0.46–5.26  0.475 
Anterior position of 
placenta** 
2.39  1.15–4.96  0.020 
Emergency C/S***  1.76  0.52–5.91  0.363 
C/S: Cesarean section. 
* Adjusted for estimated blood loss, anterior position of placenta, 
and emergency cesarean section. 
** Adjusted for estimated blood loss, preterm birth, and emergency 
cesarean section. 
*** Adjusted for estimated blood loss, preterm birth, and anterior 
position of placenta. 
 
Discussion 
It is very difficult to define neonatal anemia be-
cause the timing and site of sampling, as well as ges-
tational  age,  can  influence  blood  measurements  in 
neonatal blood [6].  
In preterm infants, hemoglobin values increase 
up until 26 gestational weeks and subsequently plat-
eau until term [2]. After birth, the increase in blood 
oxygen content and tissue oxygen delivery downreg-
ulate  erythropoietin  production,  suppressing  eryth-
ropoiesis  [7].  Among  full-term  infants,  hemoglobin 
values fall from 14.6–22.5 g/dL at birth to 10.0–12.0 
g/dL by 8–10 weeks of age; this is known as physio-
logic anemia [3]. 
The expected decline is more severe among pre-
term  infants  than  in  full-term  infants  [3].  This  is 
mainly  due  to  suboptimal  erythropoietin  response; 
shorter red blood cell lifespan; dull response of the 
fetal  liver,  which  produces  the  most  erythropoietin 
due to hypoxia; a lack of folate and vitamins B12 and E; 
and frequent blood sampling [7]. 
In  this  study,  preterm  babies  before  26  gesta-
tional weeks were excluded because there were only 5 
of them. Moreover, neonatal anemia was defined as 
venous hemoglobin concentration <14.5 g/dL within 
24 hours after birth to exclude types of physiologic 
anemia and anemia due to phlebotomy loss [3] in or-
der to identify risk factors influencing neonatal ane-
mia only before and during birth.  
As a result, preterm birth was not independently 
associated with neonatal anemia in this study. 
The high incidence of emergency cesarean sec-
tion is possibly related to the high incidence of pre-
term birth in the anemia group; however, poor neo-
natal  outcomes  such  as  low  birth  weight  and  low 
Apgar  score  [8,9]  were  not  significant  different  be-
tween groups. This is may be due to the fact that the 
353 healthy infants in whom hemoglobin levels were 
not examined were excluded from this study; there-
fore, the gestational weeks of the control group were 
lowered such that the effects of preterm birth were not 
distinctive. Int. J. Med. Sci. 2011, 8 
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This  is  the  first  study  indicating  that  anterior 
placental  location  is  an  independent  risk  factor  of 
neonatal anemia in placenta previa patients.  
However, there are only a few reports regarding 
anterior placental location in placenta previa.  
Molteni  et  al.  [10]  and  Hasegawa  et  al.  [5]  re-
ported  that  anterior  placental  location  is  associated 
with profound hemorrhage. However, its precise re-
lationship  with  neonatal  anemia,  especially  in  pla-
centa previa, has not been reported.  
McShane [11] reports a correlation between ne-
onatal  anemia  and  the  amount  of  intrapartum  ma-
ternal  blood  loss.  In  this  study,  the  risk  factors  of 
massive hemorrhage in placenta previa such as abor-
tion, previous cesarean section, complete previa, and 
placenta accreta [12-15] were not significantly higher 
in the anemia group; the only factor that correlated 
with  hemorrhage  was  anterior  placental  location. 
Consequently, massive hemorrhage (>1000 mL) was 
not significantly different between groups, although 
there was more estimated blood loss in the anemia 
group. When the placenta is in an anterior position, 
intrapartum  hemorrhage  can  occur  before  birth 
through  direct  placental  incision,  quickly  causing 
maternal  and  fetal  hemorrhage.  Although  mothers 
can sometimes tolerate this hemorrhage, it might be 
sufficient to cause neonatal anemia; we believe this 
might be the mechanism underlying our findings. 
Ogawa et al. [16] reported a case of successful 
transfundal approach, and Boehm et al. [17] reported 
2 cases of paramedian incision when the placenta was 
located in the anterior position, refusing direct pla-
cental  incision;  however,  they  did  not  evaluate  the 
effect  of  neonatal  anemia.  Furthermore,  another 
well-known  method  for  preventing  neonatal  ane-
mia—delayed  umbilical  cord  clamping—is  reported 
to be dangerous enough to increase maternal hemor-
rhage  [18];  therefore,  more  studies  on  the  optimal 
surgical approach for lowering the incidence of neo-
natal anemia are needed. 
Further prospective randomized studies includ-
ing early preterm births will help clarify these results. 
The  high  incidence  of  placenta  previa  (1.6%) 
found in this study may reflect the fact that our hos-
pitals are referral hospitals [1]. 
In  conclusion,  in  this  study,  anterior  placental 
location was an independent risk factor of neonatal 
anemia in placenta previa patients. Thus, to manage 
neonatal  anemia,  obstetricians  should  make  every 
effort to detect anterior placental location rather than 
complete previa and develop better surgical methods 
to  avoid  direct  placental  incision.  Pediatricians  also 
need to provide management while considering the 
high possibility of neonatal anemia in cases of anterior 
placental location. 
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